Abstract
Although continents recently experienced an apocalyptic pandemic that posed a mortal danger to millions of people, a new, even deadlier pandemic could soon emerge… The paper seeks to address the role played by patent waivers and current contractual arrangements in the pharmaceutical industry in addressing the dangers caused by the current and future pandemics. The process of waiving patents is explored where it is argued that it sadly cannot amount to the knight in shining armour that everyone has been expecting. Due to the lack of coordination, the tremendously long process, and the potential block in innovation arising from pharmaceutical companies having smaller incentives, more attention must be paid to other alternative institutional solutions. Drawing from the economics literature on innovation in the pharmaceutical sector, a conceptual framework is proposed for improved legal intervention in the case of patent waivers in international intellectual property law instruments. In addition, the paper provides a comparative law and economics treatment of current patent waivers in US, EU, and international law instruments.
Publisher
Katolicki Uniwersytet Lubelski Jana Pawla II
Subject
Development,Geography, Planning and Development
Reference84 articles.
1. “A Patent Waiver on Covid Vaccines Is Right and Fair.” Nature 593, no. 7860 (2021): 478. https://doi.org/https://doi.org/10.1038/d41586-021-01242-1.
2. “Advance Purchase Agreement (‘APA’)1 for the Development, Production, Ad¬vance Purchase and Supply of a COVID-19 Vaccine for EU Member States (SANTE/2020/C3/049).” European Commission, Directorate-General for Health and Food Safety, 2020.
3. Agüero, Montserrat, Isabella Monne, Azucena Sánchez, Bianca Zecchin, Alice Fusaro, María José Ruano, Manuel del Valle Arrojo, Ricardo Fernández-An¬tonio, Antonio Manuel Souto, Pedro Tordable, Julio Cañás, Francesco Bonfante, Edoardo Giussani, Calogero Terregino, and Jesús Javier Orejas. “Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in Farmed Minks, Spain, October 2022.” Eurosurveillance 28, no. 3 (2023). https://doi. org/10.2807/1560-7917.es.2023.28.3.2300001.
4. All European Academies. “Allea statement on vaccination bottlenecks in the Global South and a patent waiver for the COVID-19 vaccines.” Accessed September 14, 2023. https://www.wto.org/english/tratop_e/covid19_e/al¬lea_letter_e.pdf.
5. Amnesty International. “G7 Leaders Are Failing to Tackle Global Vaccine Ac¬cess.” August 8, 2022. https://www.amnesty.org/en/latest/news/2021/02/g7- leaders-are-shooting-themselves-in-the-foot-by-failing-to-tackle-global-vaccine-access .